Hydroxyfasudil-hydrochloride-HA-1100-hydrochloride-DataSheet-生命科學(xué)試劑-MedChemExpress_第1頁
Hydroxyfasudil-hydrochloride-HA-1100-hydrochloride-DataSheet-生命科學(xué)試劑-MedChemExpress_第2頁
Hydroxyfasudil-hydrochloride-HA-1100-hydrochloride-DataSheet-生命科學(xué)試劑-MedChemExpress_第3頁
全文預(yù)覽已結(jié)束

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEHydroxyfasudil hydrochlorideCat. No.: HY-13911ACAS No.: 155558-32-0Synonyms: HA-1100 hydrochloride; HA 1100 hydrochloride; HA1100hydrochloride分式: CHClNOS分量: 343.83作靶點(diǎn): ROCK作通路: Cell Cycle/DNA Damage; Stem Cell/Wnt; TGF-beta/Smad

2、儲(chǔ)存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性數(shù)據(jù)體外實(shí)驗(yàn) DMSO : 30 mg/mL (87.25 mM; Need ultrasonic)Mass Solvent1 mg 5 mg 10 mg Concentration制備儲(chǔ)備液1 mM 2.9084 mL 14.5421 mL 29.0841 mL5 mM 0.5817 mL 2.9084 mL 5.8168 mL10 mM 0.2908 mL 1.4542 mL 2.9084 mL請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度,選擇合適的溶劑配制儲(chǔ)

3、備液,并請(qǐng)注意儲(chǔ)備液的保存式和期限。BIOLOGICAL ACTIVITY物活性 Hydroxyfasudil hydrochloride種 ROCK 抑制劑,可抑制 ROCK1 和 ROCK2 的活性,IC50 值分別為 0.73和 0.72 M。IC50 & Target ROCK2 ROCK1 PKA0.72 M (IC50) 0.73 M (IC50) 37 M (IC50)1/2 Master of Small Molecules 您邊的抑制劑師www.MedChemE體外研究 Hydroxyfasudil hydrochloride is a ROCK inhibitor, wit

4、h IC50s of 0.73 and 0.72 M for ROCK1 and ROCK2,respectively. Hydroxyfasudil also less potently inhibits PKA, with an IC50 of 37 M, 50-fold higher than thoseof the ROCKs. Hydroxyfasudil increases eNOS mRNA levels, with an EC50 value of 0.8 0.3 M.Hydroxyfasudil (0-100 M) concentration-dependently incr

5、eases eNOS activity and stimulates NO productionin human aortic endothelial cells (HAEC). Hydroxyfasudil (10 M) increases the half-life of eNOS mRNA from13 to 16 hours, but does not affect eNOS promoter activity at concentrations from 0.1 to 100 M 1.體內(nèi)研究 Hydroxyfasudil (10 mg/kg, i.p.) significantly

6、 increases both the average and maximal voided volumes in SDrats. Hydroxyfasudil also significantly decreases the maximal detrusor pressure 2. Hydroxyfasudil (3 mg/kg,i.p) inhibits hypercontractility induced by norepinephrine in spontaneously hypertensive rats (SHRs).Furthermore, Hydroxyfasudil (3,

7、10 mg/kg, i.p) significantly ameliorates decreased penile cGMP contents inrats 3.PROTOCOLAnimal Micturition behavior is studied after intraperitoneal injection of either Hydroxyfasudil (10 mg/kg) or aAdministration 2 corresponding volume of saline. Each rat is placed in a metabolic cage containing a

8、 urine collection funnelthat is placed over an electronic balance. The balance is connected to a personal computer via a multiportcontroller and used to measure the cumulative weight of the collected urine. Every 150 s during a continuous24-h period, the computer samples and records the data for the

9、 micturition frequency and volumes. Themicturition reflex parameters that are collected includ: urine volume per micturition, maximal micturitionvolume, micturition frequency, and total urine output in the Hydroxyfasudil- or vehicle-treated animals. Eachmonitoring session started at 18.00 hours. Pri

10、or to being placed in the metabolic cage at the start of eachexperimental period, the animals receive either a single injection of Hydroxyfasudil (10 mg/kg) dissolved insaline or an injection of saline without the inhibitor 2.MCE has not independently confirmed the accuracy of these methods. They ar

11、e for reference only.戶使本產(chǎn)品發(fā)表的科研獻(xiàn) Sci Transl Med. 2018 Jul 18;10(450). pii: eaaq1093.See more customer validations on HYPERLINK / www.MedChemEREFERENCES1. Rikitake Y, et al. Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection. Stroke. 2005Oct;36(10):2251-7. Ep

12、ub 2005 Sep 1.2. Masago T, et al. Effect of the rho-kinase inhibitor hydroxyfasudil on bladder overactivity: an experimental rat model. Int J Urol. 2009Oct;16(10):842-7.3. Saito M, et al. Hydroxyfasudil ameliorates penile dysfunction in the male spontaneously hypertensive rat. Pharmacol Res. 2012Oct;66(4):325-31.McePdfHeight2/2 Master of Small Molecules 您邊的抑制劑師www.MedChemECaution

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論